Clinical Trial Update: The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating R3R01 for reducing proteinuria in patients with diabetic kidney disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• R3R01

Snippet

Sponsor: River 3 Renal Corp. | Conditions: Diabetic Kidney Disease | Phase 2 | Status: RECRUITING